Wockhardt Zaynich successfully treats paediatric cancer patient with recalcitrant blood, liver infection Ruchika Sharma1 April 2025 12:15 PM ISTThe patient was treated with Zaynich for 41 days, resulting in the successful resolution of the infection.
Wockhardt Gets CDSCO Panel Nod To study combination of cefepime and zidebactam. Dr. Divya Colin16 Jan 2024 5:00 PM ISTNew Delhi: The drug major Wockhardt has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Wockhardt begins Global Phase 3 clinical study of novel antibiotic WCK 5222 Ruchika Sharma17 Aug 2022 12:00 PM ISTWCK 5222 is being developed to treat serious Gram-negative bacterial infections which are becoming increasingly resistant to antibiotics and pose a...
